In our findings, fisetin treatment in both melanoma cells and α-MSH-stimulated melanoma cells induces JNK phosphorylation, providing a supportive pathway for MITF degradation and consequent suppression of melanin production [17,44]. Here, STAMBP is linked to melanoma.